In Sihat Global
Hospital Wearable Defibrillator
On 17, Mar 2017 | In Sihat Global | By MedikTV
ZOLL Medical, now a part of Asahi Kasei, a Japanese corporation, received FDA approval to introduce its Hospital Wearable Defibrillator (HWD) in the U.S. Intended for use on patients that may exhibit ventricular tachycardia or ventricular fibrillation (VT/VF) during their hospital stay, the HWD shares much with implantable defibrillators but can be used across multiple patients via disposable external electrodes.
When the device detects an arrhythmia, it sounds an alarm and offers the patient the option to delay the shock. If the pause button is not pressed, it warns bystanders to stay clear, and then delivers the shock. If arrhythmia continues, it will repeat the process, even multiple times. The time from arrhythmia detection to a current discharge happens in less than a minute, which will certainly be faster than delivering shocks using a manual hand-held defibrillator.
ZOLL touts that the Hospital Wearable Defibrillator uses the same arrhythmia detection technology and shock delivery as its LifeVest Wearable Defibrillator, which when studied demonstrated a 98% first shock success rate and a 92% event survival rate according to the firm.